Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
Children With and Without Allergic Asthma Experience Less Exacerbation After Receiving Dupilumab.
Read Full NewsTrial data showed that treatment with lamotrigine reduced myotonia severity in adults with genetically confirmed non-dystrophic myotonias, with sustained benefit and an acceptable safety profile.
The neurologist in the Department of Neurology at Saratoga Hospital Medical Group shared what excites her most about the future of neurology, specifically for movement disorders, in 2026.
COPD Drug Withdrawal Tied to Early Exacerbation, With Alexander Mathioudakis, MD, PhD
FDA Accepts NDA for Priority Review of Centanafadine to Treat Adult, Pediatric ADHD
FDA Approves Labeling Update for iDose TR for Open-Angle Glaucoma and Ocular Hypertension
Apecotrep Delivers 40% Proteinuria Reduction in Phase 2 FSGS Trial
FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates
1.
Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.
2.
In Resectable Lung Cancer, Perioperative Nivolumab Increases EFS.
3.
Radiotherapy after mastectomy can be avoided, study finds
4.
A garden can save your life
5.
Black women are more likely to die of breast cancer. Close the gap by looking into mammogram studies.
1.
Multiple Primary Lung Cancer: Multidisciplinary Advances in Diagnosis and Care
2.
Know About Lymphangioma: Symptoms, Causes, and Treatments
3.
Breast Cancer Recovery: Fashion, Function, and Healing Beyond Scars
4.
Unlocking the Mysteries of ICD 10 Code Normocytic Anemia
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
2.
Navigating the Complexities of Ph Negative ALL - Part IV
3.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge